<DOC>
	<DOCNO>NCT03073200</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy ixekizumab pediatric participant moderate-to-severe plaque psoriasis .</brief_summary>
	<brief_title>Study Ixekizumab ( LY2439821 ) Children 6 Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<criteria>Have diagnosis moderatetosevere plaquetype psoriasis least 6 month prior baseline determine investigator . Have PASI score ≥12 sPGA ≥3 body surface area involvement ≥10 % screen baseline . Are candidate phototherapy systemic treatment consider investigator adequately control topical therapy . Male subject agree use reliable method birth control study . Female subject woman childbearing potential test negative pregnancy agree use reliable method birth control remain abstinent study least 12 week follow last dose investigational product , whichever longer . Both child adolescent parent legal guardian able understand fully participate activity clinical study sign assent consent , respectively . All immunization uptodate agreement current immunization guideline , opinion investigator . Have pustular , erythrodermic , and/or guttate form psoriasis . Have druginduced psoriasis . Have clinical and/or laboratory evidence untreated latent active tuberculosis ( TB ) . Participants document history immune deficiency syndrome . Have active recent infection , include chronic localized infection , within 4 week baseline . Subjects know history malignancy , lymphoproliferative disease , include lymphoma , sign symptom suggestive possible lymphoproliferative disease , lymphadenopathy and/or splenomegaly . Have use therapeutic agent target reduce interleukin17 . Have receive therapy within specify timeframes : adalimumab infliximab 60 day , abatacept 90 day , anakinra 7 day , biologic diseasemodifying antirheumatic drug 5 halflives prior baseline . systemic therapy psoriasis psoriatic arthritis ( PsA ) ( , eg , methotrexate , cyclosporine ) , phototherapy ( eg , photochemotherapy [ psoralen plus ultraviolet A ] ) previous 4 week .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>child</keyword>
	<keyword>psoriasis treatment</keyword>
	<keyword>adolescent</keyword>
</DOC>